New PCSK9 Inhibitor Shows High Patient Adherence

“That’s a very important question, Luke,” Christie Ballantyne, MD, told Pharmacy Times.

Following clinical trial completion, 87% of study participants chose to enroll in the extension phase for an oral PCSK9 inhibitor, Pharmacy Times reported. According to Ballantyne, this high continuation rate demonstrates strong patient tolerability and ease of use for the once-daily medication. Patients wanted to stay in the extension as long as possible to continue receiving the treatment.

The Tech TL;DR:

• An 87% continuation rate in clinical trial extensions indicates high patient tolerability for the once-daily oral PCSK9 inhibitor.
• The medication requires a single 20-milligram morning dose taken while fasting, allowing co-administration with other drugs, water, and coffee.
• Discontinuation rates due to adverse events remained numerically lower in the treated group compared to the placebo group.

Patients Take 20 Milligrams Every Morning While Fasting

The medication maintains a single, straightforward dosage regimen of 20 milligrams administered every morning in a fasting state, Ballantyne told Pharmacy Times. While the morning fasting requirement introduces a minor routine adjustment, it mirrors common therapies such as thyroid hormone replacement. Patients can take the oral PCSK9 inhibitor alongside other prescription medications, water, and coffee.

Clinical data showed that overall discontinuations resulting from adverse events were numerically lower among treated patients than among those receiving a placebo, Pharmacy Times reported. This favorable safety profile supports primary care physicians and health care providers who are already accustomed to prescribing daily oral therapies for chronic conditions.

Pharmacists Support Long-Term Adherence Through Automated Messaging

Pharmacists can leverage automated messaging systems to notify patients when prescriptions are due for renewal, supporting ongoing maintenance for asymptomatic conditions like hyperlipidemia and hypertension, Ballantyne told Pharmacy Times. Regular feedback regarding positive lipid panel results helps reinforce patient motivation and long-term adherence.

“It would be nice if people could get their lipids checked in the pharmacy, and some pharmacies are doing that,” Ballantyne told Pharmacy Times. Effective control of both blood pressure and lipid levels has become increasingly streamlined through simple combination therapies available in outpatient settings.

Always consult with certified IT and cybersecurity professionals before altering enterprise networks or handling sensitive data.